Vaccines

American Association for Cancer Research urged the CDC to expand availability of COVID-19 booster vaccinations to caregivers and other individuals who share a home with patients with cancer.

Johnson & Johnson’s investigational HIV vaccine did not provide sufficient protection against HIV infection among women enrolled in the phase 2b Imbokodo trial in sub-Saharan Africa, the company and the NIH said Tuesday.

One of the challenges health care providers face in administering COVID-19 vaccines is vaccine hesitancy, especially among disadvantaged populations.

The AMA said today that the CPT code set has been updated to include codes for a third dose of the Moderna and Pfizer/BioNTech COVID-19 vaccines.

Immunization with recombinant quadrivalent influenza vaccines improved antibody responses at 1 month after vaccination compared with egg-based vaccines in a randomized trial conducted among health care personnel.

In this video, Janos L. Tanyi, MD, PhD, discussed findings from the “very interesting” VITAL study that assessed the potential of a novel vaccine as front-line maintenance therapy for women with ovarian cancer.

Including Black, Indigenous and people of color is necessary in photographs and studies of cutaneous reactions after the mRNA COVID-19 vaccines, according to correspondence published in The New England Journal of Medicine.

In this video, Robert Coleman, MD, FACOG, FACS, chief scientific officer of US Oncology Research, spoke with Healio about research that demonstrated the potential of a novel vaccine as front-line maintenance therapy in advanced-stage ovarian cancer.

A malaria vaccine candidate was up to 77% efficacious among children aged 5 to 17 months after 12 months of follow-up, according to findings from a phase IIb trial that were published on The Lancet’s preprint server.